American Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on American Tech Today.

Press releases published on September 28, 2026

Sep. 28, 2026

Lantheus Announces First Patient Dosed in SPARROW Phase 2/3 Registrational Trial in Prostate Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

Humacyte Expands Board Expertise with Appointment of Scott Coward and Paul Kuznik

Indeterminate GlobeNewswire

Sep. 28, 2026

4DMT Advances 4D-150 into Phase 3 for Second Large Market Retina Indication with Initiation of 4SIGHT in DME

Indeterminate GlobeNewswire

Sep. 28, 2026

Core Molding Technologies Promotes Michael J. Gayford to Chief Operating Officer

Indeterminate GlobeNewswire

Sep. 28, 2026

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

icMercury Selected for In-Orbit Validation Mission Aboard PocketQube Satellite on SpaceX Transporter-18

Indeterminate GlobeNewswire

Sep. 28, 2026

ORYZON Receives European Medicines Agency Approval to Initiate the HOPE-2 Phase II Study of Vafidemstat for the Treatment of Phelan-McDermid Syndrome (PMS)

Indeterminate GlobeNewswire

Sep. 28, 2026

GOWell Energy Technology Commences Trading on Nasdaq Under Ticker Symbol "GOW”

Indeterminate GlobeNewswire

Sep. 28, 2026

NeOnc Technologies Announces FDA End of Phase 1 Meeting for NEO212

Indeterminate GlobeNewswire

Sep. 28, 2026

Callio Therapeutics Appoints Chris Hassig, PhD, as Chief Scientific Officer

Indeterminate GlobeNewswire

Sep. 28, 2026

IPQS Expands Integration Ecosystem for Fraud Prevention and Digital Risk Intelligence

Indeterminate GlobeNewswire

Sep. 28, 2026

Immuneering Presents Data at 2026 AACR Conference on Pancreatic Cancer Supporting Atebimetinib’s Mechanisms Designed to Extend Survival in Pancreatic Cancer

Indeterminate GlobeNewswire

Sep. 28, 2026

CervoMed Announces Pharmacokinetic Results with New Neflamapimod Oral Tablet Formulation and Secures FDA Removal of Drug Exposure Limit

Indeterminate GlobeNewswire

Sep. 28, 2026

SCYNEXIS Awarded BARDA Contract Providing Up to $214 Million in Non-Dilutive Funding for the Development of SCY-247

Indeterminate GlobeNewswire

Sep. 28, 2026

TruGolf Highlights September Milestones as Polymath Acquisition Advances

Indeterminate GlobeNewswire

Sep. 28, 2026

4basebio and TriLink BioTechnologies Partner to Advance Leading Pharmaceutical Company’s Phase I Cell Therapy Program

Indeterminate GlobeNewswire

Sep. 28, 2026

CarbonStorage.io Launches Global Data Export Capabilities Across Low-Carbon Project Databases

Indeterminate GlobeNewswire

Sep. 28, 2026

Pharmazz Completes Enrollment in 160-Patient Phase 4 Trial of Sovateltide in Acute Ischemic Stroke

Indeterminate GlobeNewswire

Sep. 28, 2026

Arvinas Announces First Patient Dosed in Phase 1/2 Clinical Trial of ARV-6723, the Company’s First Immuno-Oncology Candidate

Indeterminate GlobeNewswire

Sep. 28, 2026

VisionWave Highlights STRATUM Autonomous Ground Systems Platform for Multi-Mission Defense Operations

Indeterminate GlobeNewswire